Advertisement Althea names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Althea names new CEO

US based Althea Diagnostics has appointed David Macdonald as CEO of the firm.

Mr Macdonald most recently served as president and CEO at Nanomix. He also served as president and COO of Nichols Institute Diagnostics, a division of Quest Diagnostics and as president and CEO of Progeny Systems and Medical Electronic Systems.

Francois Ferre, co-president and co-CEO of Althea, said: “We are extremely delighted to have such a seasoned leader in the diagnostics field join Althea Diagnostics. Mr David brings to the new company not only a demonstrated ability to translate diverse technologies into innovative products, but also a track record of making those products successful worldwide.”